Taiwan’s Annual Seasonal Influenza Mass Vaccination Program—Lessons for Pandemic Planning

American Journal of Public Health
September 2018   108(53)
http://ajph.aphapublications.org/toc/ajph/current

INFLUENZA
Taiwan’s Annual Seasonal Influenza Mass Vaccination Program—Lessons for Pandemic Planning
Immunization/Vaccines, Public Health Practice, Health Policy
Diane Meyer, Matthew P. Shearer, Yi-Chien Chih, Yu-Chen Hsu, Yung-Ching Lin and Jennifer B. Nuzzo
108(S3), pp. S188–S193
Abstract
Rapid medical countermeasure (MCM) dispensing is an important intervention during a public health emergency. In the United States, MCM planning and exercising efforts have largely focused on dispensing therapeutics, with less emphasis on mass vaccination operations that would require additional specialized staff and infrastructure. Difficulties in distributing vaccines during the 2009 H1N1 influenza pandemic highlighted the need for enhanced planning and exercising of plans for conducting mass vaccination campaigns.
In Taiwan, seasonal influenza mass vaccination campaigns are conducted annually, which both mitigate the effects of seasonal influenza and serve as functional exercises for mass vaccination operations during a pandemic. To identify lessons that can be applied to mass vaccination planning in the United States and elsewhere, we conducted an in-person observation and data review of Taiwan’s annual seasonal influenza mass vaccination efforts in October 2017.
We offer findings and recommendations for enhancing preparedness for seasonal and pandemic influenza and other public health emergencies that would require mass vaccination.

Key Elements for Conducting Vaccination Exercises for Pandemic Influenza Preparedness

American Journal of Public Health
September 2018   108(53)
http://ajph.aphapublications.org/toc/ajph/current

Key Elements for Conducting Vaccination Exercises for Pandemic Influenza Preparedness
Immunization/Vaccines, Public Health Practice, Injury/Emergency Care/Violence
Jonathan D. Lehnert, Danielle L. Moulia, Neil C. Murthy, Amy Parker Fiebelkorn, Sara J. Vagi, Stephanie A. Dopson and Samuel B. Graitcer
108(S3), pp. S194–S195

Cost-benefit analysis of vaccination: a comparative analysis of eight approaches for valuing changes to mortality and morbidity risks

BMC Medicine
http://www.biomedcentral.com/bmcmed/content
(Accessed 8 Sep 2018)

Research article
Cost-benefit analysis of vaccination: a comparative analysis of eight approaches for valuing changes to mortality and morbidity risks
There is increasing interest in estimating the broader benefits of public health interventions beyond those captured in traditional cost-utility analyses. Cost-benefit analysis (CBA) in principle offers a way …
Authors: Minah Park, Mark Jit and Joseph T. Wu
Citation: BMC Medicine 2018 16:139
Published on: 5 September 2018

Health promotion and the agenda for sustainable development, WHO Region of the Americas

Bulletin of the World Health Organization
Volume 96, Number 9, September 2018, 589-664
http://www.who.int/bulletin/volumes/96/9/en/
Special theme: health and the sustainable development goal

POLICY & PRACTICE
Health promotion and the agenda for sustainable development, WHO Region of the Americas
– Kira Fortune, Francisco Becerra-Posada, Paulo Buss, Luiz Augusto C Galvão, Alfonso Contreras, Matthew Murphy, Caitlin Rogger, Gabriela E Keahon & Andres de Francisco
http://dx.doi.org/10.2471/BLT.17.204404

 

 

 

 

Gender, health and the 2030 agenda for sustainable development

Bulletin of the World Health Organization
Volume 96, Number 9, September 2018, 589-664
http://www.who.int/bulletin/volumes/96/9/en/
Special theme: health and the sustainable development goals

Gender, health and the 2030 agenda for sustainable development
– Mary Manandhar, Sarah Hawkes, Kent Buse, Elias Nosrati & Veronica Magar
http://dx.doi.org/10.2471/BLT.18.211607

 

Measuring health inequalities in the context of sustainable development goals

Bulletin of the World Health Organization
Volume 96, Number 9, September 2018, 589-664
http://www.who.int/bulletin/volumes/96/9/en/
Special theme: health and the sustainable development goals

Measuring health inequalities in the context of sustainable development goals
– Ahmad Reza Hosseinpoor, Nicole Bergen, Anne Schlotheuber & John Grove
http://dx.doi.org/10.2471/BLT.18.210401

Cholera: recent updates

Current Opinion in Infectious Diseases
October 2018 – Volume 31 – Issue 5
https://journals.lww.com/co-infectiousdiseases/pages/currenttoc.aspx

GASTROINTESTINAL INFECTIONS
Cholera: recent updates
Weil, Ana A.; Ryan, Edward T.
Current Opinion in Infectious Diseases. 31(5):455-461, October 2018.
Abstract:
Purpose of review
In this review, we will examine updates in cholera epidemiology, advances in our understanding of pathogenesis and protective immunity, and changes to prevention strategies.
Recent findings
New modeling techniques and molecular epidemiology have led to advancements in our understanding of how Vibrio cholerae has persisted and re-emerged in new areas during the seventh pandemic. Use of next-generation sequencing has shed new light on immune responses to disease and vaccination, and the role of the gut microbiome in cholera. Increased efficacy and availability of vaccines have made long-term goals of global control of cholera more achievable.
Summary
Advancements in our understanding of immunity and susceptibility to V. cholerae , in addition to an increased global commitment to disease prevention, have led to optimism for the future of cholera prevention.

Is vaccinating monkeys against yellow fever the ultimate solution for the Brazilian recurrent epizootics?

Epidemiology and Infection
Volume 146 – Issue 13 – October 2018
https://www.cambridge.org/core/journals/epidemiology-and-infection/latest-issue

Arboviruses
Opinions – For Debate
Is vaccinating monkeys against yellow fever the ultimate solution for the Brazilian recurrent epizootics?
Eduardo Massad, Mônica Manir Miguel, Francisco Antonio Bezerra Coutinho
https://doi.org/10.1017/S0950268818002273
Published online: 14 August 2018, pp. 1622-1624

Mass vaccination response to a measles outbreak is not always possible. Lessons from a London prison

Epidemiology and Infection
Volume 146 – Issue 13 – October 2018
https://www.cambridge.org/core/journals/epidemiology-and-infection/latest-issue

Measles
Short Paper
Mass vaccination response to a measles outbreak is not always possible. Lessons from a London prison
 Junghans, C. Heffernan, A. Valli, K. Gibson
https://doi.org/10.1017/S0950268818001991
Published online: 19 July 2018, pp. 1689-1691
Abstract
In this study, we describe a contained measles outbreak in a London prison, the second such outbreak in a custodial setting. Once vaccination commenced, just under a third of eligible prisoners were immunised due to a low uptake of the vaccine. We conducted a root-cause analysis in order to identify factors which may have prevented or altered the course of the outbreak. Our analysis revealed that many of the factors identified are those that cannot be easily changed. It is unlikely that mass vaccination at the time, even in the absence of some of the more easily rectifiable issues, could have fully avoided further cases in the event of a mass outbreak. Both measles outbreaks in a custodial setting started with a member of staff and immunisation status of the staff were largely unknown. We argue that mass vaccination following an outbreak in a prison is unlikely to fully prevent a mass outbreak, and that implementing opt-out testing, empirical vaccination and insisting on full immunisation of staff are most likely to both prevent and contain outbreaks in the future.

 

Mandatory Health Care Provider Counseling For Parents Led To A Decline In Vaccine Exemptions In California

Health Affairs
Vol. 37 , No. 9  September 2018
https://www.healthaffairs.org/toc/hlthaff/current

September 2018 | California: Leading The Way?
Research Article  Pharmaceuticals & Medical Technology
Mandatory Health Care Provider Counseling For Parents Led To A Decline In Vaccine Exemptions In California
Malia Jones, Alison M. Buttenheim, Daniel Salmon, and Saad B. Omer
Abstract
Receipt of childhood vaccinations in the US has been declining, and outbreaks of preventable infectious diseases have become more common. In response, in 2014 California implemented a policy change for exemptions from mandatory vaccines for school enrollment. Data on fifteen successive cohorts of kindergarteners enrolled in public and private schools between school years 2001–02 and 2015–16 were analyzed for changes in vaccination trends. The results show an increase in the prevalence and clustering of vaccine exemptions from 2001–02 through 2013–14, followed by a modest decline after implementation of a policy mandating health care provider counseling for vaccine exemption. Clustering of vaccine exemptions increased over the study period and was less responsive to the policy change than were exemption rates overall. Nor did the policy change uniformly reduce the clustering of at-risk students across counties. Trends in the use of conditional admission showed strong school-level clustering and remained relatively stable. The policy change was effective at reducing exemption rates but did not uniformly reduce clustering of exemptions. The results suggest the need to evaluate the causes of local-area clustering and to adopt a statewide policy that addresses clustering of vaccine exemptions within schools and counties.

Factors Associated with Human Papillomavirus Vaccination Among Diverse Adolescents in a Region with Low Human Papillomavirus Vaccination Rates

Health Equity
Volume 2 Issue 1  Jun 2018
https://www.liebertpub.com/toc/heq/2/1

Open Access
Factors Associated with Human Papillomavirus Vaccination Among Diverse Adolescents in a Region with Low Human Papillomavirus Vaccination Rates
Deanna Kepka, Julia Bodson, Djin Lai, Ana Sanchez-Birkhead, Jeannette Villalta, Valentine Mukundente, Fahina Tavake-Pasi, France A. Davis, Doriena Lee, Edwin Napia,
Ryan Mooney, Heather Coulter, and Louisa A. Stark
Pages:223–232
Published Online:1 September 2018
https://doi.org/10.1089/heq.2018.0028
Abstract Introduction: This study assesses the sociodemographic facilitators and barriers to human papillomavirus (HPV) vaccination for diverse teens in a region with low HPV vaccination rates.

Establishing research priorities in prevention and control of vector-borne diseases in urban areas: a collaborative process

Infectious Diseases of Poverty
http://www.idpjournal.com/content
[Accessed 8 Sep 2018]

Research Article
Establishing research priorities in prevention and control of vector-borne diseases in urban areas: a collaborative process
In 2015, following a call for proposals from the Special Programme for Research and Training in Tropical Diseases (TDR), six scoping reviews on the prevention and control of vector-borne diseases in urban area…
Authors: Christian Dagenais, Stéphanie Degroote, Mariam Otmani Del Barrio, Clara Bermudez-Tamayo and Valéry Ridde
Citation: Infectious Diseases of Poverty 2018 7:85
Published on: 3 September 2018

Scoping review on vector-borne diseases in urban areas: transmission dynamics, vectorial capacity and co-infection

Infectious Diseases of Poverty
http://www.idpjournal.com/content
[Accessed 8 Sep 2018]

Scoping Review
Scoping review on vector-borne diseases in urban areas: transmission dynamics, vectorial capacity and co-infection
Transmission dynamics, vectorial capacity, and co-infections have substantial impacts on vector-borne diseases (VBDs) affecting urban and suburban populations. Reviewing key factors can provide insight into pr…
Authors: Marcus Eder, Fanny Cortes, Noêmia Teixeira de Siqueira Filha, Giovanny Vinícius Araújo de França, Stéphanie Degroote, Cynthia Braga, Valéry Ridde and Celina Maria Turchi Martelli
Citation: Infectious Diseases of Poverty 2018 7:90
Published on: 3 September 2018

Rotavirus massive vaccination in Argentina: better than we expected

International Journal of Infectious Diseases
August 2018 Volume 73, Supplement, p1-398
https://www.ijidonline.com/issue/S1201-9712(18)X0007-1
18th ICID abstract supplement 2018

Rotavirus massive vaccination in Argentina: better than we expected
Although Latin America has seen a rapid and successful introduction of rotavirus vaccines since 2006, Argentina only incorporated monovalent vaccine into its National Immunization Program in 2015. No specific surveillance strategy has yet been designed to accurately measure the impact of this recent introduction on the diarrheal disease burden in our country. Thus, we assessed post-vaccine introduction data (all-cause acute diarrhea and rotavirus laboratory confirmed cases, and genotype distribution), compared to pre-vaccination period in children under 5 years of age in Argentina.
Degiuseppe, J. Stupka
Published in issue: August 2018

Oral Rehydration Therapy for Diarrheal Diseases: A 50-Year Perspective

JAMA
September 4, 2018, Vol 320, No. 9, Pages 849-948
http://jama.jamanetwork.com/issue.aspx

Viewpoint
Oral Rehydration Therapy for Diarrheal Diseases: A 50-Year Perspective
Roger I. Glass, MD, PhD; Barbara J. Stoll, MD
JAMA. 2018;320(9):865-866. doi:10.1001/jama.2018.10963
In this Viewpoint, Roger I. Glass traces the discovery of the oral rehydration solution during a cholera epidemic in Bangladesh in the 1960s to treat severe diarrhea by promoting electrolyte balance and attributes oral rehydration therapy with saving hundreds of thousands of lives in the last 50 years

Gaps in the Clinical Management of Influenza – A Century Since the 1918 Pandemic

JAMA
September 4, 2018, Vol 320, No. 9, Pages 849-948
http://jama.jamanetwork.com/issue.aspx

Gaps in the Clinical Management of Influenza – A Century Since the 1918 Pandemic
Timothy M. Uyeki, MD, MPH, MPP; Robert A. Fowler, MD, MDCM, MSc; William A. Fischer II, MD
JAMA. 2018;320(8):755-756. doi:10.1001/jama.2018.8113
This Viewpoint reviews advances in the surveillance, diagnosis, and treatment of influenza since the 1918 pandemic, and identifies key clinical questions to address in advance of the next outbreak, including optimal treatment for hospitalized and critically ill patients and those with secondary bacterial pneumonia.

Real-World Evidence and Real-World Data for Evaluating Drug Safety and Effectiveness

JAMA
September 4, 2018, Vol 320, No. 9, Pages 849-948
http://jama.jamanetwork.com/issue.aspx

Real-World Evidence and Real-World Data for Evaluating Drug Safety and Effectiveness
Jacqueline Corrigan-Curay, JD, MD; Leonard Sacks, MD; Janet Woodcock, MD
JAMA. 2018;320(9):867-868. doi:10.1001/jama.2018.10136
In this Viewpoint, Janet Woodcock and CDER colleagues discuss recent FDA initiatives to investigate the adequacy of electronic health record (EHR) and patient database data for research purposes and to understand if and how real-world observational data might be analyzed in ways that mimic or can be as reliable as randomized trials.

 

Promoting Patient Interests in Implementing the Federal Right to Try Act

JAMA
September 4, 2018, Vol 320, No. 9, Pages 849-948
http://jama.jamanetwork.com/issue.aspx

Promoting Patient Interests in Implementing the Federal Right to Try Act
Holly Fernandez Lynch, JD, MBE; Patricia J. Zettler, JD; Ameet Sarpatwari, JD, PhD
JAMA. 2018;320(9):869-870. doi:10.1001/jama.2018.9880
This Viewpoint reviews provisions of the US Right to Try Act, which allows patients with life-threatening conditions access to investigational drugs without FDA approval, and calls for clarifications around patient and drug eligibility, reporting requirements, and differences from the FDA’s Expanded Access program to minimize potential harms from the law.

Costs, Consequences, and Policy Responses of Vaccine-Preventable Disease Outbreaks

JAMA Pediatrics
September 2018, Vol 172, No. 9, Pages 793-896
http://archpedi.jamanetwork.com/issue.aspx

Editorial
Costs, Consequences, and Policy Responses of Vaccine-Preventable Disease Outbreaks
Jason L. Schwartz, PhD
Abstract
Vaccine hesitancy poses a growing threat to the success of vaccination efforts worldwide. In the United States, support for routine childhood vaccination, as reflected in national vaccination rates, has remained very strong despite concerns among some parents over the necessity or safety of recommended vaccines.1 However, national vaccination coverage data mask the presence of clusters of large numbers of unvaccinated children in specific communities,2 which understates the risks of vaccine-preventable diseases for these individuals and those around them, as well as the magnitude of the challenge that public health officials face when outbreaks occur in these areas.

Effectiveness of Live Attenuated vs Inactivated Influenza Vaccines in Children During the 2012-2013 Through 2015-2016 Influenza Seasons in Alberta, CanadaA Canadian Immunization Research Network (CIRN) Study

JAMA Pediatrics
September 2018, Vol 172, No. 9, Pages 793-896
http://archpedi.jamanetwork.com/issue.aspx

Original Investigation
Effectiveness of Live Attenuated vs Inactivated Influenza Vaccines in Children During the 2012-2013 Through 2015-2016 Influenza Seasons in Alberta, CanadaA Canadian Immunization Research Network (CIRN) Study
Sarah A. Buchan, PhD; Stephanie Booth, MPH; Allison N. Scott, PhD; et al.
Key Points
Question
Does vaccine effectiveness differ between live attenuated influenza vaccine and inactivated influenza vaccine in children and adolescents?
Findings
This test-negative study compared health administrative data and laboratory test results on respiratory specimens from 10,169 children and adolescents across 4 influenza seasons and found no significant differences in the odds of influenza infection between children who received live attenuated and those who received inactivated influenza vaccine. The only exception was influenza B during the 2015-2016 season, for which live attenuated influenza vaccine provided better protection than inactivated influenza vaccine.
Meaning
These results support receipt of either live attenuated influenza vaccine or inactivated influenza vaccine in this age group.

Duty to provide care to Ebola patients: the perspectives of Guinean lay people and healthcare providers

Journal of Medical Ethics
September 2018 – Volume 44 – 9
http://jme.bmj.com/content/current

Global medical ethics
Duty to provide care to Ebola patients: the perspectives of Guinean lay people and healthcare providers (22 August, 2018)
Aim To examine the views of Guinean lay people and healthcare providers (HCPs) regarding the acceptability of HCPs’ refusal to provide care to Ebola patients.
Lonzozou Kpanake, Tamba Kallas Tonguino, Paul Clay Sorum, Etienne Mullet

 

Facing up to the global challenges of ageing

Nature 
Volume 561 Issue 7721, 6 September 2018
http://www.nature.com/nature/current_issue.html

Review Article | 05 September 2018
Facing up to the global challenges of ageing
Linda Partridge, Joris Deelen & P. Eline Slagboom
Abstract
Longer human lives have led to a global burden of late-life disease. However, some older people experience little ill health, a trait that should be extended to the general population. Interventions into lifestyle, including increased exercise and reduction in food intake and obesity, can help to maintain healthspan. Altered gut microbiota, removal of senescent cells, blood factors obtained from young individuals and drugs can all improve late-life health in animals. Application to humans will require better biomarkers of disease risk and responses to interventions, closer alignment of work in animals and humans, and increased use of electronic health records, biobank resources and cohort studies.

Antibodies and tuberculosis: finally coming of age?

Nature Reviews Immunology
Volume 18 Issue 9, September 2018
https://www.nature.com/nri/volumes/18/issues/8

Perspective | 05 June 2018
Antibodies and tuberculosis: finally coming of age?
Most candidate vaccines for tuberculosis are designed to boost cell-mediated immunity to Mycobacterium tuberculosis, the intracellular bacterium that causes the disease. This Opinion article considers the rationale for also harnessing antibody-mediated immunity in future tuberculosis vaccines.
Hao Li  & Babak Javid

A New Threat to Immigrants’ Health — The Public-Charge

New England Journal of Medicine
September 6, 2018   Vol. 379 No. 10
http://www.nejm.org/toc/nejm/medical-journal

Perspective
A New Threat to Immigrants’ Health — The Public-Charge
Krista M. Perreira, Ph.D., Hirokazu Yoshikawa, Ph.D., and Jonathan Oberlander, Ph.D.
[Initial text]
The United States is making major changes to its immigration policies that are spilling over into health policy. In one such change, the Trump administration is drafting a rule on “public charges” that could have important consequences for access to medical care and the health of millions of immigrants and their families.1 The concept of a public charge dates back to 19th-century immigration law. Under current guidelines, persons labeled as potential public charges can be denied legal entry to the United States. They can also be prevented from adjusting their status from a nonimmigrant visa category (e.g., a student or work visa) to legal permanent resident status. In addition, if they become public charges within the first 5 years after their admission to the United States, for reasons that existed before they came to the country, in rare cases they can be arrested and deported. Immigrants and their families consequently have strong incentives to avoid being deemed public charges.
Current guidelines define a public charge as a person who is primarily dependent on the government for more than half of personal income. In evaluating whether a person is likely to become a public charge, immigration officials take account of factors such as age, health, financial status, education, and skills…

The Violence of Uncertainty — Undermining Immigrant and Refugee Health

New England Journal of Medicine
September 6, 2018   Vol. 379 No. 10
http://www.nejm.org/toc/nejm/medical-journal

The Violence of Uncertainty — Undermining Immigrant and Refugee Health
Breanne L. Grace, Ph.D., Rajeev Bais, M.D., M.P.H., and Benjamin J. Roth, Ph.D., M.S.W.
Immigrants and refugees in the United States have long faced structural violence due to unequal health care access. Now they’re being subjected to “the violence of uncertainty,” enacted through systematic instability that exacerbates inequality and generates fear.

Legislation to Increase Uptake of HPV Vaccination and Adolescent Sexual Behaviors

Pediatrics
September 2018, VOLUME 142 / ISSUE 3
http://pediatrics.aappublications.org/content/142/3?current-issue=y

Articles
Legislation to Increase Uptake of HPV Vaccination and Adolescent Sexual Behaviors
Erin E. Cook, Atheendar S. Venkataramani, Jane J. Kim, Rulla M. Tamimi, Michelle D. Holmes
Pediatrics Sep 2018, 142 (3) e20180458; DOI: 10.1542/peds.2018-0458
Legislation to raise uptake of HPV vaccination among adolescents was not associated with increases in risky sexual behavior in this quasi-experimental study

Prenatal Tetanus, Diphtheria, Acellular Pertussis Vaccination and Autism Spectrum Disorder

Pediatrics
September 2018, VOLUME 142 / ISSUE 3
http://pediatrics.aappublications.org/content/142/3?current-issue=y

Prenatal Tetanus, Diphtheria, Acellular Pertussis Vaccination and Autism Spectrum Disorder
Tracy A. Becerra-Culqui, Darios Getahun, Vicki Chiu, Lina S. Sy, Hung Fu Tseng
Pediatrics Sep 2018, 142 (3) e20180120; DOI: 10.1542/peds.2018-0120
In this retrospective observational cohort study, we evaluate the association between Tdap vaccination during pregnancy and ASD in children in an integrated health care system in Southern California.

Primary Ovarian Insufficiency and Adolescent Vaccination

Pediatrics
September 2018, VOLUME 142 / ISSUE 3
http://pediatrics.aappublications.org/content/142/3?current-issue=y

Primary Ovarian Insufficiency and Adolescent Vaccination
Allison L. Naleway, Kathleen F. Mittendorf, Stephanie A. Irving, Michelle L. Henninger, Bradley Crane, Ning Smith, Matthew F. Daley, Julianne Gee
Pediatrics Sep 2018, 142 (3) e20180943; DOI: 10.1542/peds.2018-0943
We investigated the risk for young women of developing POI after adolescent vaccination. No increased risk was observed.

Adoption of Serogroup B Meningococcal Vaccine Recommendations

Pediatrics
September 2018, VOLUME 142 / ISSUE 3
http://pediatrics.aappublications.org/content/142/3?current-issue=y

Adoption of Serogroup B Meningococcal Vaccine Recommendations
Allison Kempe, Mandy A. Allison, Jessica R. MacNeil, Sean T. O’Leary, Lori A. Crane, Brenda L. Beaty, Laura P. Hurley, Michaela Brtnikova, Megan C. Lindley, Alison P. Albert
Pediatrics Sep 2018, 142 (3) e20180344; DOI: 10.1542/peds.2018-0344
We examined how primary care physicians are adopting the MenB vaccine after it received a category B recommendation by the ACIP in 2015.

Meningococcal B Vaccine Immunogenicity in Children With Defects in Complement and Splenic Function

Pediatrics
September 2018, VOLUME 142 / ISSUE 3
http://pediatrics.aappublications.org/content/142/3?current-issue=y

Meningococcal B Vaccine Immunogenicity in Children With Defects in Complement and Splenic Function
Federico Martinón-Torres, Ewa Bernatowska, Anna Shcherbina, Susanna Esposito, Leszek Szenborn, Magda Campins Marti, Stephen Hughes, Saul N. Faust, Luis I. Gonzalez-Granado, Ly-Mee Yu, Diego D’Agostino, Marco Calabresi, Daniela Toneatto, Matthew D. Snape
Pediatrics Sep 2018, 142 (3) e20174250; DOI: 10.1542/peds.2017-4250
Children with complement deficiency respond less well to immunization with 4CMenB than healthy children in the control category; surveillance for vaccine failures is required to determine the significance of this.

Understanding FDA-Approved Labeling and CDC Recommendations for Use of Vaccines

Pediatrics
September 2018, VOLUME 142 / ISSUE 3
http://pediatrics.aappublications.org/content/142/3?current-issue=y

Special Articles
Understanding FDA-Approved Labeling and CDC Recommendations for Use of Vaccines
Cody Meissner, Karen Farizo, Douglas Pratt, Larry K. Pickering, Amanda C. Cohn
Pediatrics Sep 2018, 142 (3) e20180780; DOI: 10.1542/peds.2018-0780
Recommendations for the use of FDA-licensed vaccines are provided by the CDC. In this article, we discuss why a difference may exist between licensure and recommendations for vaccine use.

Using Evidence from Randomised Controlled Trials in Economic Models: What Information is Relevant and is There a Minimum Amount of Sample Data Required to Make Decisions?

PharmacoEconomics
Volume 36, Issue 10, October 2018
https://link.springer.com/journal/40273/36/10/page/1

Current Opinion
Using Evidence from Randomised Controlled Trials in Economic Models: What Information is Relevant and is There a Minimum Amount of Sample Data Required to Make Decisions?
John W. Stevens

Barriers to supportive care during the Ebola virus disease outbreak in West Africa: Results of a qualitative study

PLoS One
http://www.plosone.org/
[Accessed 8 Sep 2018]

Research Article
Barriers to supportive care during the Ebola virus disease outbreak in West Africa: Results of a qualitative study
During the 2013–2016 West Africa Ebola outbreak, supportive care was the only non-experimental treatment option for patients with Ebola virus disease (EVD). However, providing care that would otherwise be routine for most clinical settings in the context of a highly contagious and lethal pathogen is much more challenging. The objective of this study was to document and deepen understanding of barriers to provision of supportive care in Ebola treatment units (ETUs) as perceived by those involved in care delivery during the outbreak
Christine Loignon, Elysée Nouvet, François Couturier, Lynda Benhadj, Neill K. J. Adhikari, Srinivas Murthy, Rob A. Fowler, François Lamontagne
Research Article | published 05 Sep 2018 PLOS ONE
https://doi.org/10.1371/journal.pone.0201091
 

 

Vaccination against pertussis and influenza in pregnancy: a qualitative study of barriers and facilitators

Public Health
September 2018 Volume 162, p1-154
http://www.publichealthjrnl.com/current

Original Research
Vaccination against pertussis and influenza in pregnancy: a qualitative study of barriers and facilitators
Anna Maisa, Sarah Milligan, Alison Quinn, Denise Boulter, Jillian Johnston, Charlene Treanor, Declan T. Bradley
Published online: July 14, 2018

Quadrivalent Meningococcal Vaccine Uptake Among Men Who Have Sex With Men During a Meningococcal Outbreak in Los Angeles County, California, 2016-2017

Public Health Reports
Volume 133 Issue 5, September/October 2018
http://phr.sagepub.com/content/current

Research
Quadrivalent Meningococcal Vaccine Uptake Among Men Who Have Sex With Men During a Meningococcal Outbreak in Los Angeles County, California, 2016-2017
Ian W. Holloway, PhD, MSW, MPH, Elizabeth S. C. Wu, MPH, Jennifer Gildner, MSPH, Vincent L. Fenimore, PhD, MEd, Diane Tan, MSPH, Laura Randall, MPH, Paula M. Frew, PhD, MA, MPH
First Published September 6, 2018; pp. 559–569

The role of National Immunisation Technical Advisory Groups (NITAGs) in strengthening national vaccine decision-making: A comparative case study of Armenia, Ghana, Indonesia, Nigeria, Senegal and Uganda

Vaccine
Volume 36, Issue 37  Pages 5495-5670 (5 September 2018)
https://www.sciencedirect.com/journal/vaccine/vol/36/issue/36

Research article   Open access
The role of National Immunisation Technical Advisory Groups (NITAGs) in strengthening national vaccine decision-making: A comparative case study of Armenia, Ghana, Indonesia, Nigeria, Senegal and Uganda
Natasha Howard, Helen Walls, Sadie Bell, Sandra Mounier-Jack
Pages 5536-5543

Factors influencing vaccine acceptance and hesitancy in three informal settlements in Lusaka, Zambia

Vaccine
Volume 36, Issue 37  Pages 5495-5670 (5 September 2018)
https://www.sciencedirect.com/journal/vaccine/vol/36/issue/36

Research article  Open access
Factors influencing vaccine acceptance and hesitancy in three informal settlements in Lusaka, Zambia
Miguel Pugliese-Garcia, Leonard W. Heyerdahl, Chanda Mwamba, Sharon Nkwemu, … Anjali Sharma
Pages 5617-5624